Aktive Positionen von Ronald Bronsaer
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CellMade SAS
CellMade SAS Medical SpecialtiesHealth Technology CellMade SAS develops inflammatory biomarkers for drug discovery and clinical diagnostics. The firm's services include inflammation bio bank, inflammation discovery, anti-inflammatory toxicity and companion diagnostics. Its products and services are used in a range of applications from research and development to drug screening. The company was founded by Ronald Bronsaer in 2007 and is headquartered in Marseille, France. | Vorstandsvorsitzender | 24.06.2009 | - |
Vorsitzender | 24.06.2009 | - | |
Gründer | 01.01.2007 | - |
Karriereverlauf von Ronald Bronsaer
Ehemalige bekannte Positionen von Ronald Bronsaer
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CAMBREX CORPORATION | Corporate Officer/Principal | 01.01.2007 | 01.01.2007 |
Statistik
International
Frankreich | 2 |
Vereinigte Staaten | 2 |
Operativ
Chief Executive Officer | 1 |
Chairman | 1 |
Founder | 1 |
Sektoral
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
CellMade SAS
CellMade SAS Medical SpecialtiesHealth Technology CellMade SAS develops inflammatory biomarkers for drug discovery and clinical diagnostics. The firm's services include inflammation bio bank, inflammation discovery, anti-inflammatory toxicity and companion diagnostics. Its products and services are used in a range of applications from research and development to drug screening. The company was founded by Ronald Bronsaer in 2007 and is headquartered in Marseille, France. | Health Technology |
Cambrex Corp.
Cambrex Corp. Pharmaceuticals: GenericHealth Technology Cambrex Corp. engages in the provision of products, services, and technologies to accelerate and improve the development and commercialization of new and generic therapeutics. It supplies to innovator and generic pharmaceutical companies. Its products include generic and branded APIs, controlled substances, chiral compounds, high potency APIs, and advanced intermediates. The company was founded by Arthur Mendolia and Cyril C. Baldwin Jr. in 1981 and is headquartered in East Rutherford, NJ. | Health Technology |
- Börse
- Insiders
- Ronald Bronsaer
- Erfahrung